Oragenics, Inc. , a company focused on developing unique, intranasal nanoparticle pharmaceuticals for the treatment of neurological disorders, today announced that it intends to offer to sell shares.
Oragenics (OGEN) Announces Proposed Public Offering streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of Oragenics (NYSEAMERICAN:OGEN – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the biotechnology company’s stock. Oragenics Stock Performance NYSEAMERICAN OGEN opened at $3.69 on Friday. The stock has a fifty day moving average of $3.52. Oragenics has a 1-year […]
SARASOTA, Fla. Oragenics, Inc. (NYSE American: OGEN) (the “Company”), a company focused on developing unique, intranasal nanoparticle pharmaceuticals for…
Oragenics, Inc. , a company focused on developing unique, intranasal nanoparticle pharmaceuticals for the treatment of neurological disorders, today announced that its engagement agreement with its.